| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 38 |
| 1 | METHOTREXATE SODIUM | 36 |
| 2 | TACROLIMUS | 36 |
| 3 | ASPIRIN | 35 |
| 4 | ASPIRIN 325 MG | 35 |
| 5 | ASPIRIN 81 MG | 35 |
| 6 | INFLIXIMAB | 35 |
| 7 | OMEPRAZOLE | 34 |
| 8 | METHOTREXATE | 32 |
| 9 | ISONIAZID | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0139 |
| 1 | PROTEIN C CONCENTRATE HUMAN | 1 | 0.0125 |
| 2 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 3 | ISONIAZID | 31 | 0.0019 |
| 4 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| 5 | HEPARIN SODIUM AND DEXTROSE | 1 | 0.0014 |
| 6 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 7 | FROVATRIPTAN SUCCINATE | 1 | 0.0013 |
| 8 | BIVALIRUDIN | 1 | 0.0010 |
| 9 | BASILIXIMAB | 12 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 75 |
| 1 | Corticosteroid [EPC] | 61 |
| 2 | Factor Xa Inhibitor [EPC] | 51 |
| 3 | Proton Pump Inhibitor [EPC] | 45 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 38 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 37 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 32 |
| 7 | Antimycobacterial [EPC] | 31 |
| 8 | Antirheumatic Agent [EPC] | 30 |
| 9 | Aminosalicylate [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimycobacterial [EPC] | 31 | 0.0013 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 4 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | Vitamin K [EPC] | 4 | 0.0005 |
| 7 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 9 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |